Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies.
Li YR, Fang Y, Niu S, Zhu Y, Chen Y, Lyu Z, Zhu E, Tian Y, Huang J, Rezek V, Kitchen S, Hsiai T, Zhou JJ, Wang P, Chai-Ho W, Park S, Seet CS, Oliai C, Yang L.
Li YR, et al. Among authors: zhou jj.
Nat Commun. 2025 Feb 1;16(1):1248. doi: 10.1038/s41467-025-56270-6.
Nat Commun. 2025.
PMID: 39893165